Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Physical & Chemical properties

Particle size distribution (Granulometry)

Currently viewing:

Administrative data

Link to relevant study record(s)

Referenceopen allclose all

Endpoint:
particle size distribution (granulometry)
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
04 April 2013 - 13 May 2013
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Qualifier:
according to guideline
Guideline:
other: OECD 436
Deviations:
not specified
Principles of method if other than guideline:
This study is submitted as supporting data as the data are taken from an acute inhalation study where the substance was ground prior to generation of an atmosphere. The study does not therefore necessarily reflect the particle size of the substance as it is placed on the market.
GLP compliance:
yes (incl. QA statement)
Remarks:
Date of Inspection: 10 July 2012, Date of signature: 30 November 2012
Type of distribution:
other: Gravimetric
Specific details on test material used for the study:
Sponsor's identification: IP37: Copper (II)-pyrophosphate
Description: Pale green powder
CAS No. 10102-90-6
EC No. 233-279-4
Batch number: 9000022795
Purity: > 80 % (based on Cu content > 34 %)
Impurities: < 18 % water, < 2 % free othophosphate, pyrophosphate
Expiry Date: 29 September 2014
Storage conditions: Room temperature, in the dark
Mass median aerodynamic diameter:
>= 1.99 - <= 3.06 µm
Geometric standard deviation:
>= 2.14 - <= 2.67

The particle size analysis of the atmosphere drawn from the animals’ breathing zone, was as follows: 

 

Group Number

Mean Achieved

Atmosphere

Concentration (mg/L)

Mean Mass Median

Aerodynamic Diameter

(μm)

Inhalable Fraction

(% <4 μm)

Geometric Standard

Deviation

1

5.16

3.06

60.9

2.67

2

1.08

1.99

82.3

2.14

Conclusions:
The Mean Mass Median Aerodynamic Diameter was reported to be 3.06 μm for group 1 animals and 1.99 μm for group 2 animals. The inhalable fraction (rat) of the test material ( % <4 μm) was 60.9% for group 1 and 82.3% for group 2, which would allow the test material to reach upper and lower regions of the respiratory tract of the test animal.
Executive summary:

The Mean Mass Median Aerodynamic Diameter was reported to be 3.06 μm for group 1 animals and 1.99 μm for group 2 animals. The inhalable fraction (rat) of the test material ( % <4 μm) was 60.9% for group 1 and 82.3% for group 2, which would allow the test material to reach upper and lower regions of the respiratory tract of the test animal.

This study is conducted according to an appropriate guideline and under the conditions of GLP, the study is therefore considered to be acceptable and to adequately satisfy both the guideline requirement and the regulatory requirement as a key study for this endpoint.

Endpoint:
particle size distribution (granulometry)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
Study was completed on 18th March
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
comparable to guideline study
Qualifier:
according to guideline
Guideline:
other: European Commission Technical Guidance Document EUR 20268 ' Determination of Particle Size Distribution, Fibre Length and Diameter Distribution' of Chemical Substances (2002).
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Date of inspection: 10 July 2012, Date of signature: 30 November 2012
Type of method:
sieving
Type of distribution:
volumetric distribution
Specific details on test material used for the study:
-Identification: IP37: Copper (II)-pyrophosphate
- Description: Pale blue powder
- Batch number: 9000022795
- Composition: P2O5 (39.15 % w/w), CuO (43.52 % w/w)
- Expiry date: 29 September 2014
- Storage Conditions: Room temperature, in the dark
Key result
Percentile:
D90
Mean:
<= 100 µm
Remarks on result:
other: no standard deviation determined
No.:
#1
Size:
< 100 µm
Distribution:
94.6 %

The results of the sieving are shown in the following table:

 

Measurement

Result

Mass of test item transferred to sieve

12.52 g

Mass of test item passed through sieve

11.84 g

Proportion of test item < 100µm

94.6%

Conclusions:
The proportion of the test material having an inhalable particle size of less than 100 µm was determined to be 94.6 %, therefore the test item has been considered to be essentially inhalable.
No further particle size fractions were assessed for the test item.
Endpoint:
particle size distribution (granulometry)
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Qualifier:
no guideline followed
Principles of method if other than guideline:
Test material was sieved in an alpine air jet sieving machine.
GLP compliance:
no
Type of method:
sieving
Type of distribution:
volumetric distribution
Specific details on test material used for the study:
- Name of test material (as cited in study report): copper (II) pyrophosphate (Kupferhydroxidphosphat)
Key result
Percentile:
D99
Mean:
<= 100 µm
No.:
#1
Size:
< 100 µm
Distribution:
100 %
Conclusions:
100% of particles were found to be < 100 µm in diameter and as such the particle size distribution indicates copper(II) pyrophosphate is an inhalation risk (a significant proportion of the particles are present at < 100 µm).
Executive summary:

100 % of particles were found to be < 100 µm in diameter and as such the particle size distribution indicates copper(II) pyrophosphate is an inhalation risk (a significant proportion of the particles are present at < 100 µm).

This study is considered to be appropriate and reliable for use as a key study in accordance with Regulation (EC) No. 1907/2006 (REACH). No further testing is required.

Description of key information

The proportion of the test item having an inhalable size of less than 100 µm was determined to be 94.6 % using a sieve method.

Additional information

Three studies exist (company test data, MMAD as reported in an OECD 403 study and a particle size distribution study). The results from the particle size distribution study have been chosen as the key study.

The proportion of the test item having an inhalable size of less than 100 µm was determined to be 94.6 % using a sieve method, procedure designed to be compatible with European Commission Technical Guidance Document EUR 20268 ' Determination of Particle Size Distribution, Fibre Length and Diameter Distribution of Chemical Substances (2002)'. No further particle size fractions were assessed.